When Can We Go Back to Normal for Developing Standards?
نویسندگان
چکیده
منابع مشابه
Hodgkin's lymphoma in developing countries: can we go further?☆
Hodgkin’s lymphoma (HL) is a B cell malignancy that affects approximately 8000 new patients in the United States annually.1 This is the most common lymphoma affecting the young population with a higher incidence at ages 15 to 35 years. Because of its particular histological features and biological behavior, HL is highly responsive to chemotherapy and radiation, and therefore is considered a mod...
متن کاملWhen Can We Lift the Coronavirus Pandemic Restrictions? Not Before Taking These Steps
When Can We Lift the Coronavirus Pandemic Restrictions? Not Before Taking These Steps. The American Enterprise Institute, a public policy think tank, recently released a report co-written by former U.S. Food and Drug Administration commissioner Scott Gottlieb that offers a four-phase “road map to reopening.” The first phase involves slowing the spread of new infections with physical distancing ...
متن کاملwhen can we release the amplatzer ductal occluder (ado) safely?
background: the ductus arteriosus connects the main pulmonary trunk to the descending aorta. the incidence of isolated patent ductus arteriosus (pda) in full-term infants is about 1 in 2000. the amplatzer ductal occluder (ado) is recommended for pdas with sizes larger than 2 mm. in this procedure, we must confirm the ado position in pda by aortogram from the arterial line. the purpose of this s...
متن کاملDiagnostic and therapeutic challenges for dermatologists: What shall we do when we don’t know what to do?
What shall we do when we have done everything we could for the diagnosis and treatment of a patient, but were not successful? What shall we do when there is no definite treatment for a patient? What shall we do when we have no diagnosis or treatment for a patient? Some useful suggestions are presented here to get rid of these situations.
متن کاملSugarcane improvement: how far can we go?
In recent years, efforts to improve sugarcane have focused on the development of biotechnology for this crop. It has become clear that sugarcane lacks tools for the biotechnological route of improvement and that the initial efforts in sequencing ESTs had limited impact for breeding. Until recently, the models used by breeders in statistical genetics approaches have been developed for diploid or...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: IEEE Communications Standards Magazine
سال: 2021
ISSN: 2471-2825,2471-2833
DOI: 10.1109/mcomstd.2021.210111